VEGF and ALS

Azzouz, 2004, VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model, Nature, 429, 413, 10.1038/nature02544

Bogaert, 2006, Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases, Muscle Nerve, 34, 391, 10.1002/mus.20609

Brockington, 2007, Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in amyotrophic lateral sclerosis, BMC Med. Genet., 8, 23, 10.1186/1471-2350-8-23

Brockington, 2006, Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis, J. Neuropathol. Exp. Neurol., 65, 26, 10.1097/01.jnen.0000196134.51217.74

Brockington, 2005, Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis, Neurogenetics, 6, 101, 10.1007/s10048-004-0201-4

Chen, 2007, Association of polymorphisms in vascular endothelial growth factor gene with the age of onset of amyotrophic lateral sclerosis, Amyotroph. Lateral Scler., 8, 144, 10.1080/17482960601179373

Chen, 2006, Lack of association of VEGF promoter polymorphisms with sporadic ALS, Neurology, 67, 508, 10.1212/01.wnl.0000227926.42370.04

Chen, 2004, DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4), Am. J. Hum. Genet., 74, 1128, 10.1086/421054

Cozzolino, 2008, Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications, Antioxid. Redox Signal., 10, 405, 10.1089/ars.2007.1760

Del Bo, 2006, Neurobiol. Aging, 29, 314, 10.1016/j.neurobiolaging.2006.10.008

Devos, 2004, Low levels of the vascular endothelial growth factor in CSF from early ALS patients, Neurology, 62, 2127, 10.1212/01.WNL.0000129913.44351.A3

Dewil, 2007, Vascular endothelial growth factor counteracts the loss of phosphor-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis, Neuropathol. Appl. Neurobiol., 33, 499, 10.1111/j.1365-2990.2007.00850.x

Fernández-Santiago, 2006, Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS, Neurology, 66, 1929, 10.1212/01.wnl.0000219756.71928.25

Ferrara, 1999, Role of vascular endothelial growth factor in the regulation of angiogenesis, Kidney Int., 56, 794, 10.1046/j.1523-1755.1999.00610.x

Ferrara, 1989, Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells, Biochem. Biophys. Res. Commun., 161, 851, 10.1016/0006-291X(89)92678-8

Fong, 1999, Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice, Development, 126, 3015, 10.1242/dev.126.13.3015

Gitcho, 2008, TDP-43 A315T mutation in familial motor neuron disease, Ann. Neurol., 63, 535, 10.1002/ana.21344

Gros-Louis, 2003, Absence of mutations in the hypoxia response element of VEGF in ALS, Muscle Nerve, 28, 774, 10.1002/mus.10498

Hand, 2003, Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis, Arch. Neurol., 60, 1768, 10.1001/archneur.60.12.1768

Hiratsuka, 1998, Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice, Proc. Natl. Acad. Sci. U.S.A., 95, 9349, 10.1073/pnas.95.16.9349

Iłżecka, 2004, Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, Clin. Neurol. Neurosurg., 106, 289, 10.1016/j.clineuro.2003.12.007

Just, 2007, High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia, Neuromuscul. Disord., 17, 169, 10.1016/j.nmd.2006.10.004

Kabashi, 2008, TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis, Nat. Genet., 40, 572, 10.1038/ng.132

Kieran, 2005, A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice, J. Cell. Biol., 169, 561, 10.1083/jcb.200501085

Lambrechts, 2008, Meta-analysis of VEGF variations in ALS: increased susceptibility in male carriers of the −2578AA genotype, J. Med. Genet. Epub. ahead of print

Lambrechts, 2003, VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death, Nat. Genet., 34, 383, 10.1038/ng1211

Lemmens, 2007, Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish, Hum. Mol. Genet., 16, 2359, 10.1093/hmg/ddm193

Li, 2003, VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death, Brain Res. Mol. Brain Res., 111, 155, 10.1016/S0169-328X(03)00025-1

Lu, 2007, Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression, Neurobiol. Dis., 27, 7929

Matsumoto, 2001, VEGF receptor signal transduction, Sci. STKE, 112, RE21

Moreau, 2006, Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS, J. Neurol. Neurosurg. Psychiatry, 77, 255, 10.1136/jnnp.2005.070904

Nagano, 2005, Therapeutic benefit of intrathecal injections of insulin-like growth factor-1 in a mouse model of amyotrophic lateral sclerosis, J. Neurosci. Sci., 235, 61, 10.1016/j.jns.2005.04.011

Nagata, 2007, Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients, Neurol. Res., 29, 772, 10.1179/016164107X229795

Neufeld, 2002, The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis, Trends Cardiovasc. Med., 12, 13, 10.1016/S1050-1738(01)00140-2

Neumann, 2006, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130, 10.1126/science.1134108

Nicholas, 2001, Health among commercial airline pilots, Aviat. Space Environ. Med., 72, 821

Nicholas, 1998, Mortality among US commercial pilots and navigators, J. Occup. Environ. Med., 40, 980, 10.1097/00043764-199811000-00008

Nishimura, 2004, A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis, Am. J. Hum. Genet., 75, 822, 10.1086/425287

Nygren, 2002, VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis, Neuroreport, 13, 2199, 10.1097/00001756-200212030-00007

Oates, 2007, An epigenetic analysis of SOD1 and VEGF in ALS, Amyotroph. Lateral Scler., 8, 83, 10.1080/17482960601149160

Oosthuyse, 2001, Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration, Nat. Genet., 28, 131, 10.1038/88842

Pamphlett, 2002, Mutations in the VEGF promoter and ALS in airline pilots: a link? J, Occup. Environ. Med., 44, 987, 10.1097/00043764-200211000-00001

Raab, 2007, Different networks, common growth factors: shared growth factors and receptors of the vascular and nervous system, Acta Neuropathol., 113, 607, 10.1007/s00401-007-0228-3

Rosen, 1993, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 362, 59, 10.1038/362059a0

Sathasivam, 2005, Apoptosis in amyotrophic lateral sclerosis—what is the evidence?, Lancet Neurol., 4, 500, 10.1016/S1474-4422(05)70142-3

Senger, 1983, Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid, Science, 219, 983, 10.1126/science.6823562

Shalaby, 1995, Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice, Nature, 376, 62, 10.1038/376062a0

Shaw, 2005, Molecular and cellular pathways of neurodegeneration in motor neurone disease, J. Neurol. Neurosurg. Psychiatry, 76, 1046, 10.1136/jnnp.2004.048652

Spliet, 2004, Immunohistochemical localization of vascular endothelial growth factor receptors-1 -2 and -3 in human spinal cord: altered expression in amyotrophic lateral sclerosis, Neuropathol. Appl. Neurobiol., 30, 351, 10.1111/j.1365-2990.2003.00543.x

Sreedharan, 2008, TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis, Science, 319, 1668, 10.1126/science.1154584

Storkebaum, 2005, Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS, Nat. Neurosci., 1, 85, 10.1038/nn1360

Takahashi, 2005, The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions, Clin. Sci., 109, 227, 10.1042/CS20040370

Terry, 2004, VEGF promoter haplotype and amyotrophic lateral sclerosis (ALS), J. Neurogenet., 18, 429, 10.1080/01677060490894450

Tolosa, 2008, Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase, J. Neurochem., 105, 1080, 10.1111/j.1471-4159.2007.05206.x

Tovar-y-Romo, 2007, Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration, J. Neuropathol. Exp. Neurol., 66, 913, 10.1097/nen.0b013e3181567c16

Van Deerlin, 2008, TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis, Lancet Neurol., 7, 409, 10.1016/S1474-4422(08)70071-1

Van Den Bosch, 2004, Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration, Neurobiol. Dis., 17, 21, 10.1016/j.nbd.2004.06.004

Van Vught, 2005, Lack of association between VEGF polymorphisms and ALS in a Dutch population, Neurology, 65, 1643, 10.1212/01.wnl.0000184514.39853.56

Wang, 2007, Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice, J. Neurosci., 27, 304, 10.1523/JNEUROSCI.4433-06.2007

Xie, 2004, Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 rats, Neuroreport, 15, 2513, 10.1097/00001756-200411150-00016

Yang, 2001, The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis, Nat. Genet., 29, 160, 10.1038/ng1001-160

Zhang, 2006, VEGF C2578A polymorphism does not contribute to amyotrophic lateral sclerosis susceptibility in sporadic Chinese patients, Amyotroph. Lateral Scler., 7, 119, 10.1080/14660820600600657

Zheng, 2004, Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS, Ann. Neurol., 56, 564, 10.1002/ana.20223

Zheng, 2007, VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice, Biochem. Biophys. Res. Commun., 363, 989, 10.1016/j.bbrc.2007.09.088